MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

26 May 2025 Evaluate
The company witnessed a 15.36% growth in the revenue at Rs. 1544.72 millions for the quarter ended March 2025 as compared to Rs. 1338.99 millions during the year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 115.92 millions grew from Rs.-320.01 millionsOperating profit for the quarter ended March 2025 rose to 253.28 millions as compared to 224.87 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1544.72 1338.99 15.36 5426.02 4734.18 14.61 5426.02 4734.18 14.61
Other Income 135.72 64.53 110.32 194.04 86.86 123.39 194.04 86.86 123.39
PBIDT 253.28 224.87 12.63 1018.31 849.51 19.87 1018.31 849.51 19.87
Interest 60.76 60.11 1.08 279.04 296.80 -5.98 279.04 296.80 -5.98
PBDT 192.52 -278.52 -169.12 739.27 109.43 575.56 739.27 109.43 575.56
Depreciation 75.31 72.98 3.19 279.18 276.20 1.08 279.18 276.20 1.08
PBT 117.21 -351.50 -133.35 460.09 -166.77 -375.88 460.09 -166.77 -375.88
TAX 1.29 -31.49 -104.10 30.79 -23.49 -231.08 30.79 -23.49 -231.08
Deferred Tax 1.29 -31.49 -104.10 30.79 -37.05 -183.10 30.79 -37.05 -183.10
PAT 115.92 -320.01 -136.22 429.30 -143.28 -399.62 429.30 -143.28 -399.62
Equity 157.92 137.99 14.44 157.92 137.99 14.44 157.92 137.99 14.44
PBIDTM(%) 16.40 16.79 -2.37 18.77 17.94 4.59 18.77 17.94 4.59
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..